IMMUNE PHARMACEUTICALS INC Uncategorized Contracts & Agreements

33 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Nominee Agreement between Cytovia International LLC and Noventia Pharma SRL regarding European Market Authorizations for Ceplene® and Other Products
Agency Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
2018
Standby Financing Agreement between Immune Pharmaceuticals, Inc. and Daniel Kazado (June 14, 2017)
Financing Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2017
Asset Purchase Agreement between Meda Pharma SARL and Immune Pharmaceuticals, Inc. for Ceplene and Related Assets
Purchase Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
2017
Interim CEO Employment Agreement between Immune Pharmaceuticals Inc. and Elliot Maza (May 2017)
Employment Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2017
Separation and Consulting Agreement between Immune Pharmaceuticals Inc. and Gad Berdugo
Separation Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
2015
Securities Exchange Agreement between Immune Pharmaceuticals Inc. and Preferred Holder (July 16, 2015)
Exchange Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2015
Amendment and Termination Agreement between Immune Pharmaceuticals Inc. and Endo Pharmaceuticals Inc.
Modification Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2015
EpiCept Corporation Director Resignation and Transition Services Agreement with Robert G. Savage
Separation Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
2013
EpiCept Corporation Director Resignation and Compensation Agreement with Alan Dunton
Separation Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
2013
EpiCept Corporation Director Resignation and Compensation Agreement with Keith Brownlie
Separation Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
2013
Exclusive Placement Agent Agreement between EpiCept Corporation and Dawson James, Inc. for Warrant Exercise
Warrant Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2012
EpiCept Corporation Letter Agreement for Warrant Exercise and Preferred Stock Repricing with Security Holder
Modification Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
2012
Consent Agreement Regarding Asset Sale by EpiCept Corporation, Maxim Pharmaceuticals Inc., and Cytovia, Inc. to Meda AB and Meda Pharma SARL
IMMUNE PHARMACEUTICALS INC
Biotechnology
MD
2012
License and Supply Agreement among EpiCept Corporation, EpiCept GmbH, and MEDA AB dated January 8, 2010
License Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2010
Supplementary Agreement to Repayment Agreement between tbg Technologie-Beteiligungs-Gesellschaft mbH and Epicept GmbH
Modification Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
2009
Placement Agent Agreement between EpiCept Corporation and Rodman & Renshaw, LLC (June 18, 2009)
Equity Distribution Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2009
Placement Agent Agreement between EpiCept Corporation and Rodman & Renshaw, LLC (February 4, 2009)
Equity Distribution Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2009
Indenture Agreement for 7.5556% Convertible Subordinated Notes Due 2014 between EpiCept Corporation and The Bank of New York Mellon
Indenture Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2009
Indenture Agreement for 7.5824% Convertible Subordinated Notes Due 2014 between EpiCept Corporation and The Bank of New York Mellon
Indenture Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2009
Indenture Agreement between EpiCept Corporation and The Bank of New York Mellon for Convertible Debt Securities
Indenture Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2008
EpiCept Corporation Preliminary Prospectus Supplement for Common Stock and Warrants Offering with Rodman & Renshaw, LLC as Placement Agent
Warrant Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
2008
Placement Agent Agreement between EpiCept Corporation and Rodman & Renshaw, LLC (May 28, 2008)
Financing Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2008
Subordinated Capital Investment Agreement between IKB and Pharmed Labs GmbH (March 31, 1998)
Financing Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
2005
First Amendment Agreement, dated as of January 15, 2019, by and between Immune Pharmaceuticals Inc. and Discover Growth Fund, LLC
IMMUNE PHARMACEUTICALS INC
Biotechnology
2019
Common Stock Purchase Agreement between Immune Pharmaceuticals Inc. and HLHW IV, LLC dated March 22, 2017
Purchase Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2017
Common Stock Purchase Agreement between Immune Pharmaceuticals Inc. and HLHW IV, LLC dated February 3, 2017
Purchase Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2017
Immune Pharmaceuticals Inc. $1,050,000 Convertible Note Agreement with HLHW IV, LLC (November 17, 2016)
Note Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2016
Binding Securities Purchase Agreement between Immune Pharmaceuticals Inc., Novel Pain Therapeutics, LLC, and Maxim Pharmaceuticals, Inc.
Purchase Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
2016
Capital Access Agreement between Immune Pharmaceuticals Inc. and Regatta Select Healthcare, LLC (June 10, 2016)
Purchase Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2016
Amendment No. 1 to Capital Access Agreement between Immune Pharmaceuticals Inc. and Regatta Select Healthcare LLC
Modification Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
2016
Capital Access Agreement between Immune Pharmaceuticals Inc. and Regatta Select Healthcare, LLC (April 19, 2016)
Purchase Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
NY
2016
Employment Agreement between Immune Pharmaceuticals Inc. and Monica Luchi (Executive Vice President and Chief Medical Officer)
Employment Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
2016
Amendment Agreement between Immune Pharmaceuticals Inc. and Investor (August 13, 2014)
Modification Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
2014